Stryker

Cartiva is a medical device company based in the United States that specializes in the development of innovative products for the treatment of first metatarsophalangeal joint osteoarthritis. The Cartiva SCI, the company's flagship product, is a novel osteochondral defect repair implant designed to replicate the properties of natural cartilage and has been approved by the FDA for the treatment of this condition.